Recent Developments in the Treatment of Clear Cell, Renal Cell Carcinoma: Essential Insights and Updates for the Healthcare Team

Target Audience
Oncology, Managed care and Specialty Pharmacists and Oncology Nurses/Nurse Practitioners

Program Overview
The goal of this educational initiative is to equip oncology nurse practitioners and nurses, as well as oncology, managed care, and specialty care pharmacists with the knowledge to apply findings from risk scoring systems used to stratify cases of clear cell renal cell carcinoma for treatment selection, differentiate among an expanding array of combination regimens containing immune checkpoint inhibitors and targeted therapies, and elevate the standard of care for patients by mitigating the incidence and severity of immune-related adverse events tied to the use of medications gaining widespread adoption in routine clinical practice.

Learning Objectives
Upon completion of this activity, participants should be better able to:

Discuss factors used to stratify patients diagnosed with clear cell renal cell carcinoma to determine treatment
Describe the efficacy and tolerability profiles of current and emerging combination regimens for clear cell renal cell carcinoma consisting of targeted therapies and immune checkpoint inhibitors
Formulate individualized care strategies that minimize the severity and frequency of adverse events associated with combination strategies for clear cell renal cell carcinoma